Ionis Pharmaceuticals (IONS) Operating Leases (2021 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Operating Leases of $262.5 million for Q2 2026, up 59.68% year-over-year from $164.4 million in Q2 2025, and up 1.26% quarter-over-quarter from $259.2 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Operating Leases (2021 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Operating Leases history runs 6 years deep, the most recent figure standing at $262.5 million for Q2 2026.
- In Q2 2026, Operating Leases rose 59.68% year-over-year to $262.5 million; the TTM figure through Jun 2026 stood at $262.5 million (up 59.68% YoY), while the FY2025 annual figure was $262.4 million, up 62.16% from the prior year.
- Operating Leases for Q2 2026 stood at $262.5 million, up from $259.2 million in the prior quarter.
- The five-year high for Operating Leases was $262.7 million in Q3 2025, with the low at $159.4 million in Q1 2025.
- The 5-year median for Operating Leases is $173.0 million (2023), against an average of $194.0 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases surged 820.86% in 2022, then slipped 5.5% in 2025.
- Ionis Pharmaceuticals' Operating Leases stood at $178.9 million in 2022, then retreated by 4.51% to $170.9 million in 2023, then slipped by 5.31% to $161.8 million in 2024, then jumped by 62.16% to $262.4 million in 2025, then gained by 0.04% to $262.5 million in 2026.
- Business Quant data shows IONS's Operating Leases at $262.5 million in Q2 2026, $259.2 million in Q1 2026, and $262.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 262.48 Mn |
| Mar 31, 2026 | 259.22 Mn |
| Dec 31, 2025 | 262.38 Mn |
| Sep 30, 2025 | 262.67 Mn |
| Jun 30, 2025 | 164.38 Mn |
| Mar 31, 2025 | 159.39 Mn |
| Dec 31, 2024 | 161.81 Mn |
| Sep 30, 2024 | 168.37 Mn |
| Jun 30, 2024 | 166.44 Mn |
| Mar 31, 2024 | 168.67 Mn |
| Dec 31, 2023 | 170.88 Mn |
| Sep 30, 2023 | 173.04 Mn |
| Jun 30, 2023 | 175.02 Mn |
| Mar 31, 2023 | 177.00 Mn |
| Dec 31, 2022 | 178.94 Mn |
| Dec 31, 2021 | 19.43 Mn |